Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients

Journal of Thrombosis and Thrombolysis

Volumn 28, Issue 3, 2009, Pages 362-365

  Lippi, Giuseppe ^a   Franchini, Massimo ^b   Targher, Giovanni ^a   Montagnana, Martina ^a   Salvagno, Gian Luca ^a   Guidi, Gian Cesare ^a   Favaloro, Emmanuel J ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Activated partial thromboplastin time; Fibrinogen; Prothrombin time; Thrombosis; Thyroid stimulating hormone

Indexed keywords

FIBRINOGEN; THYROTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; EUTHYROIDISM; FEMALE; FIBRINOGEN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERCOAGULABILITY; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FIBRINOGEN; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; OUTPATIENTS; PARTIAL THROMBOPLASTIN TIME; RETROSPECTIVE STUDIES; THROMBOPHILIA;

EID: 70349130014     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-008-0269-z     Document Type: Article

References (26)

1. Weissel M (2006) Disturbances of thyroid function in the elderly. Wien Klin Wochenschr 118:16-20
2. Franchini M (2006) Hemostatic changes in thyroid diseases: Haemostasis and thrombosis. Hematology 11:203-208
3. Squizzato A, Romualdi E, Büller HR, Gerdes VE (2007) Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis - a systematic review. J Clin Endocrinol Metab 92:2415-2420
4. Nielsen HK (1991) Pathophysiology of venous thromboembolism. Semin Thromb Hemost 17(Suppl 3):250-253
5. Peralta AR, Canhão P (2008) Hypothyroidism and cerebral vein thrombosis - a possible association. J Neurol Jun 20 [Epub ahead of print]
6. Squizzato A, Romualdi E, Piantanida E et al (2007) Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study. Thromb Haemost 97:803-806
7. Squizzato A, Vitale J, Gerdes VE, Romualdi E, Büller HR, Ageno W (2007) Recurrent deep venous thrombosis during optimal anticoagulation and overt hyperthyroidism: A case report. Blood Coagul Fibrinolysis 18:801-803
8. Romualdi E, Squizzato A, Ageno W (2008) Venous thrombosis: A possible complication of overt hyperthyroidism. Eur J Intern Med 19:386-387
9. Dai A, Wasay M, Dubey N, Giglio P, Bakshi R (2000) Superior sagittal sinus thrombosis secondary to hyperthyroidism. J Stroke Cerebrovasc Dis 9:89-90
10. Tiede DJ, Tefferi A, Kochhar R, Thompson GB, Hay ID (1994) Paraneoplastic cholestasis and hypercoagulability associated with medullary thyroid carcinoma. Cancer 73:702-705
11. Rawlins ML, Roberts WL (2004) Performance characteristics of six-third-generation assays for thyroid-stimulating hormone. Clin Chem 50:2338-2344
12. Baloch Z, Carayon P, Conte-Devolx B, Guidelines Committee National Academy of Clinical Biochemistry et al (2003) Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3-12
13. Rogers JS, Shane SR (1982) Jencks FS (1982) Factor VIII activity and thyroid function. Ann Intern Med 97:713-716
14. Erem C, Ersoz HO, Karti SS, Ukinç K, Hacihasanoglu A, Deǧer O, Telatar M (2002) Blood coagulation and fibrinolysis in hyperthyroidism. J Endocrinol Invest 25:345-350
15. Akinci B, Comlekci A, Yener S, Demir T, Ozcan MA, Bayraktar F, Yesil S (2007) Thrombin activatable fibrinolysis inhibitor antigen levels are inversely correlated with plasminogen activator inhibitor-1 antigen levels in hyperthyroid patients. Endocr J 54:593-599
16. Morikawa Y, Morikawa A, Makino I (1993) Relationship of thyroid states and serum thrombomodulin (TM) levels in patients with Grave's disease: TM a possible new marker of the peripheral activity of thyroidhormones. J Clin Endocrinol Metab 76:609-614
17. Marongiu F, Conti M, Mameli G et al (1988) Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment. J Endocrinol Invest 11:723-725
18. Coban E, Aydemir M (2008) Levels of plasma fibrinogen and D-dimer in subjects with subclinical hyperthyroidism. Med Sci Monit 14:CR42-CR46
19. Altinova AE, Törüner FB, Aktürk M, Bukan N, Cakir N, Ayvaz G, Arslan M (2006) Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism. Clin Endocrinol (Oxf) 65:530-535
20. Dörr M, Robinson DM, Wallaschofski H, Schwahn C, John U, Felix SB, Völzke H (2006) Low serum thyrotropin is associated with high plasma fibrinogen. J Clin Endocrinol Metab 91:530-534
21. Erem C (2006) Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: Subclinical hyperthyroidism increases plasma factor X activity. Clin Endocrinol (Oxf) 64:323-329
22. Lord ST (2007) Fibrinogen and fibrin: Scaffold proteins in hemostasis. Curr Opin Hematol 14:236-241
23. Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM (2004) A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 104:3631-3634
24. Tripodi A, Mannucci PM (2006) Activated partial thromboplastin time (APTT). New indications for an old test? J Thromb Haemost 4:750-751
25. Hron G, Eichinger S, Weltermann A, Quehenberger P, Halbmayer WM, Kyrle PA (2006) Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time. J Thromb Haemost 4:752-756
26. Legnani C, Mattarozzi S, Cini M, Cosmi B, Favaretto E, Palareti G (2006) Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal. Br J Haematol 134:227-232